Miriam Antonucci
Overview
Explore the profile of Miriam Antonucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palermiti A, Billi M, De Nicolo A, Cusato J, Manca A, Antonucci M, et al.
Biomed Pharmacother
. 2025 Feb;
184:117873.
PMID: 39913972
One of the principal challenges in managing hypertension is suboptimal medication adherence, which can result in up to 50 % of patients experiencing pseudo-resistant hypertension and inadequate blood pressure control....
2.
Cusato J, Mulasso A, Ferrara M, Manca A, Accardo G, Palermiti A, et al.
Antioxidants (Basel)
. 2025 Jan;
14(1).
PMID: 39857416
High levels of reactive oxygen species (ROS) are present in people living with HIV (PLWH), produced by intense physical activity; in response, our body produces antioxidant molecules. ROS influence the...
3.
Cusato J, Ribaldone D, D Avolio A, Infusino V, Antonucci M, Caviglia G, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685734
: Vitamin D (VD) has immunoregulatory properties, generating interest in its potential to influence therapeutic outcomes in inflammatory bowel disease (IBD), other than affecting the expression of genes encoding enzymes...
4.
Palermiti A, De Nicolo A, Manca A, Antonucci M, Mula J, Billi M, et al.
J Med Chem
. 2024 Dec;
67(24):22124-22133.
PMID: 39630959
Antihypertensive pharmacological therapy is often characterized by a coadministration of different classes of drugs. Therefore, analytical methods allowing the simultaneous quantification of many drugs are needed for therapeutic drug monitoring...
5.
Calcagno A, Cusato J, Cinque P, Marchetti G, Bernasconi D, Trunfio M, et al.
Brain
. 2024 Aug;
147(11):3742-3750.
PMID: 39171829
It is debated whether CNS involvement begins during acute human immunodeficiency virus (HIV) infection in persons without meningitis/encephalitis and whether specific antiretroviral drugs or combinations would be beneficial. Neurologically asymptomatic...
6.
Cusato J, Mulasso A, Ferrara M, Manca A, Antonucci M, Accardo G, et al.
Antioxidants (Basel)
. 2024 May;
13(5).
PMID: 38790623
Background: Physical activity could increase the production of oxidative stress biomarkers, affecting the metabolism and excretion of antiretroviral drugs and, consequently, the clinical outcome. Nowadays, people living with HIV (PLWH)...
7.
Manca A, Valz C, Chiara F, Mula J, Palermiti A, Billi M, et al.
Biomed Pharmacother
. 2024 May;
175:116686.
PMID: 38713939
The phytocomplex of Cannabis is made up of approximately 500 substances: terpeno-phenols metabolites, including Δ-9-tetrahydrocannabinol and cannabidiol, exhibit pharmacological activity. Medical Cannabis has several pharmacological potential applications, in particular in...
8.
Cusato J, Ribaldone D, Falzone M, Manca A, Antonucci M, Palermiti A, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672179
Over the years, vedolizumab (VDZ) has emerged as a more effective target therapy for inflammatory bowel disease. The aim of this work was to analyze a cohort of inflammatory bowel...
9.
Palermiti A, Manca A, Mastrantonio F, Maiese D, Curatolo A, Antonucci M, et al.
Molecules
. 2024 Apr;
29(7).
PMID: 38611915
Vitamin D (Vit D) is a fat-soluble molecule acting like a hormone, and it is involved in several biological mechanisms such as gene expression, calcium homeostasis, bone metabolism, immune modulation,...
10.
Cusato J, Manca A, Palermiti A, Mula J, Avataneo V, Antonucci M, et al.
Int J Antimicrob Agents
. 2024 Mar;
63(6):107137.
PMID: 38508536
Objectives: Blood-brain barrier impairment is frequent in people living with human immunodeficiency virus (PLWHIV), affecting the penetration of target cells and antiretrovirals into the central nervous system, through transporters (e.g....